PROSOLV® ODT G2 is a high functionality excipient for orally disintegrating tablet formulation, development, and manufacture. This innovative orally disintegrating tablet (ODT) matrix is a unique combination of soluble and insoluble ingredients manufactured using JRS Pharma's co-processing technology.
It provides a pleasing, convenient, and discreet form of administration for active pharmaceutical and nutritional ingredients without the need for water. PROSOLV® ODT G2 offers the functional performance needed for today's orally disintegrating tablet formulation challenges and complies with globally accepted and monographed raw materials.
PROSOLV® ODT G2 addresses formulation and manufacturing challenges with a robust functional performance that high-speed tablet manufacturing requires. Patients experience tablets with pleasing mouth-feel and fast disintegration in the oral cavity, with no need for water.
PROSOLV® ODT G2 offers:
ODT Excipient Matrix
Average Particle Size by Laser Diffraction (µm)
Bulk Density (g/mL)
PROSOLV® ODT G2
0.45 – 0.65
PROSOLV® ODT G2 is a simple-to-use co-processed composite derived from JRS PHARMA’s patented PROSOLV® Technology. Its primary application is for the development and manufacture of orally disintegrating tablets allowing the discrete and convenient administering of medicines without water for high patient compliance.